EARLY AND LONG-TERM RESULTS OF VACCINATION: NEW TOOLS FOR SUSTAINABLE MANAGEMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
https://doi.org/10.21518/2079-701X-2016-15-42-45
Abstract
Adequate management of patients with chronic obstructive pulmonary disease (COPD) is not getting less relevant year by year. Sustainable management of the patient requires additional tools and methods as well as approaches to evaluating the effectiveness of treatment schemes. It is known that the ability of drugs to improve functional parameters does not always lead to an improvement in patients’ well-being or enhance their daily living. In this regard, it is especially important to evaluate the quality of life as a marker of treatment efficacy. The aim of the study was to evaluate the effect of vaccination on the quality of life in patients with COPD during a 3-year follow up. Material and Methods: 362 male patients diagnosed with COPD were included in the study. 13-valent conjugate pneumococcal vaccine Prevenar-13 (PCV13) and polyvalent Pnevmo23 pneumococcal vaccine (PPV23) were used in vaccination. The quality of life (QoL) evaluation was done using two questionnaires, the Russian version of the St. George Hospital Respiratory Questionnaire (SGRQ) and the universal COPD assessment test (CAT). Results and conclusions: vaccination with PCV13 and PPV23 had a positive impact on the quality of life in the first year after vaccination, but the effect of PPV23 decreased in the third year of follow-up. Quality of life questionnaires allow to focus on the right treatment strategy both in early and long-term follow up of patients with COPD.
About the Authors
G. L. IGNATOVA
South Ural State Medical University, Ministry of Health of Russia, Chelyabinsk
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
V. N. ANTONOV
South Ural State Medical University, Ministry of Health of Russia, Chelyabinsk
Russian Federation
Russian Federation
O. V. RODIONOVA
South Ural State Medical University, Ministry of Health of Russia, Chelyabinsk
Russian Federation
Russian Federation
References
1. Колосов В.П., Трофимова А.Ю., Нарышкина С.В. Качество жизни больных хронической обструктивной болезнью легких. Благовещенск, 2011. 132 с. [Kolosov V.P., Trofimova A.Y., Naryshkina S.V. Quality of life in patients with chronic obstructive pulmonary disease. Blagoveschensk, 2011. 132].
2. Чучалин А.Г. Хроническая обструктивная болезнь легких – 2009: итоги первой декады нового тысячелетия. Consilium medicum, Экстравыпуск, 2009: [Chuchalin A.G. Chronic obstructive pulmonary disease – 2009: results of the first decade of the new millennium. Consilium medicum, Extra issue, 2009: 3].
3. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (GOLD), 2016.
4. Глобальная стратегия диагностики, лечения и профилактики хронической обструктивной болезни легких (пересмотр 2011 г.). Пер. с англ. под ред. А.С. Белевского. М.: Российское респираторное общество, 2012. 80 с. [Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, 2011. Trans. from English A.S. Belevsky. M.: Russian Respiratory Society, 2012. 80 p].
5. Синопальников А.И., Зайцев А.А. Современный взгляд на фармакотерапию обострений хронической обструктивной болезни легких. Медицинские новости, 2010, 10: 13-17. [Sinopalnikov A.I., Zaitsev A.A. Current view on drug treatment of exacerbations of chronic obstructive pulmonary disease. Meditsinskiye Novosti, 2010 10: 13-17].
6. Дворецкий Л.И. Инфекционное обострение ХОБЛ. Лечащий врач, 2007, 03/07. [Dvoretsky L.I. An infectious exacerbation of COPD. Lechaschiy Vrach, 2007, 03/07].
7. Чучалин А.Г., Синопальников А.И., Козлов Р.С. Инфекционное обострение ХОБЛ: практические рекомендации по диагностике, лечению и профилактике. Пособие для врачей. Москва. 2005. 37 с. [Chuchalin A.G., Sinopalnikov A.I., Kozlov R.S. An infectious exacerbation of COPD: guidelines for diagnosis, treatment and prevention. Manual for physicians. Moscow. 2005. 37 p].
8. Авдеев С.Н. Могут ли современные лекарственные средства модифицировать течение ХОБЛ? Терапевтический архив, 2008, 8: 80-86. [ Avdeev S.N. Can modern drugs modify the course of COPD? Terapevticheskiy Arkhiv, 2008, 8: 80-86].
9. Новик А.А., Ионова Т.И. Руководство по исследованию качества жизни в медицине Под ред. акад. РАМН Ю. Л. Шевченко, 2-е изд. М.: ЗАО «ОЛМА Медиа Групп», 2007. 320 с. [Novik A.A., Ionova T.I. A guide to the study of quality of life in medicine / Ed. by RAMS Acad. Yu. L. Shevchenko, 2nd ed. M .: OLMA Media Groupb ZAO, 2007. 320 p].
10. The MRC breathlessness scale addapted from Fletcher C.M. Discussion on the Diagnosis of Pulmonary Emphysema. J R Soc Med, 1952, September, 45: 576-586.
11. Белевский А.С. САТ-тест – диалог на одном языке с пациентом. 19-й Национальный конгресс по болезням органов дыхания. Сборник резюме. М., 2009. С. 225. [Belevsky A.S. CAT: a common-language dialogue with the patient. 19th National Congress on Respiratory Diseases. A collection of abstracts. Moscow, 2009. P. 225].
12. St. George’s Hospital Respiratory Questionnaire. URL: http://www.healthstatus.sgul.ac.uk. (дата обращения: 01.07.2016).
13. Игнатова Г.Л., Антонов В.Н., Родионова О.В. Экономическая оценка вакцинопрофилактики больных хронической обструктивной болезнью легких и ишемической болезнью сердца. Пульмонология, 2015, 3: 312-319. [Ignatova G.L., Antonov V.N., Rodionova O.V. Economic evaluation of vaccination in patients with chronic obstructive pulmonary disease and coronary artery disease. Pulmonologiya, 2015, 3: 312-319].
14. Костинов М.П., Протасов А.Д. Перспективные данные применения пневмококковой 13-валентной коньюгированной вакцины у взрослых пациентов с хронической бронхолегочной патологией. Пульмонология, 2014, 4: 57-62. [Kostinov M.P., Protasov A.D. Prospective data on the application of pneumococcal 13-valent conjugate vaccine in adult patients with chronic bronchopulmonary pathology. Pulmonologiya, 2014, 4: 57-62].
Review
For citations:
IGNATOVA GL, ANTONOV VN, RODIONOVA OV. EARLY AND LONG-TERM RESULTS OF VACCINATION: NEW TOOLS FOR SUSTAINABLE MANAGEMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Meditsinskiy sovet = Medical Council. 2016;(15):42-45. (In Russ.) https://doi.org/10.21518/2079-701X-2016-15-42-45
Views:
627
Email this article 